Neoadjuvant Immunotherapy of Operable Metastatic Melanoma in Real Life (GCC)

Clinical trial NCT06586593 · RECRUITING

Trial details

NCT number: NCT06586593
Sponsor: Centre Hospitalier Universitaire de Besancon
Status: RECRUITING
Study type: OBSERVATIONAL

Melanoma Metastatic

Start date: 2023-03-24
Primary completion: 2025-01-01
Enrollment: 77

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.